Analyzing How Zhizi Baipi Decoction Regulates VEGF to Suppress RA Angiogenesis Using Network Pharmacology and Experimental Validation
Phytochemical Analysis · 2025
DOI: 10.1002/pca.3508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemical Analysis, 2025. Verfasst von Jing Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Network Pharmacology, Arthritis, Rheumatoid, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Major Natural Science Research Projects of Anhui Province Colleges and Universities, Excellent and Top Talents Cultivation Project of Anhui Province Colleges and Universities.
Abstract (Originalsprache)
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily manifests with symptoms such as heat and toxin. However, the key components and molecular mechanisms of Zhizi Baipi decoction (ZBD) in the treatment of RA are still unclear.
Objectives
The study aimed to explore the mechanism of action of ZBD for treating RA through ingredient analysis, network pharmacology, and experimental validation. Material and Methods The chemical constituents of ZBD were identified by ultra‐high performance liquid chromatography coupled with Q‐TOF‐mass spectrometry (UPLC‐Q‐TOF‐MS E ). Additionally, the active ingredients of ZBD treating RA were screened by network pharmacology and using molecular docking to verify the binding energy of the active ingredients and ZBD's targets. Then we elucidated ZBD's mechanism of action on collagen‐induced arthritis (CIA) model rats. Subsequently, experimental validations were used to validate the findings of network pharmacology.
Results
A total of 84 chemical constituents was identified by UPLC‐Q‐TOF‐MS E . The results of network pharmacology indicated that ZBD could exert its therapeutic effect on RA through the vascular endothelial growth factor (VEGF) pathway. Molecular docking revealed a strong binding capacity between the target KDR and the active ingredients. Additionally, we quantified the five active ingredients of ZBD. In vivo experiments demonstrated that ZBD inhibited synovial angiogenesis and alleviated the occurrence and progression of RA.
Conclusion
Overall, ZBD has a significant therapeutic effect on RA. The results of qualitative analysis, network pharmacology, molecular docking, and in vivo experiments indicated that the main active components of ZBD could modulate the VEGF pathway to treat RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
- Key Laboratory of Xin'an Medicine, Ministry of Education, Hefei, China.
- Anhui Province Key Laboratory of Chinese Medicinal Formula, Anhui University of Chinese Medicine, Hefei, China.
ORCID-Profile: Hong Wu
Förderung
- National Natural Science Foundation of China
- Major Natural Science Research Projects of Anhui Province Colleges and Universities
- Excellent and Top Talents Cultivation Project of Anhui Province Colleges and Universities
Zitieren
APA
Xu, J., Zhu, Y., Wei, Y., Gan, P., Xia, S., Li, Y., Jiang, X., Wang, Y., & Wu, H. (2025). Analyzing How Zhizi Baipi Decoction Regulates VEGF to Suppress RA Angiogenesis Using Network Pharmacology and Experimental Validation. Phytochemical Analysis. https://doi.org/10.1002/pca.3508
Vancouver
Xu J, Zhu Y, Wei Y, Gan P, Xia S, Li Y, et al. Analyzing How Zhizi Baipi Decoction Regulates VEGF to Suppress RA Angiogenesis Using Network Pharmacology and Experimental Validation. Phytochemical Analysis. 2025. doi:10.1002/pca.3508
BibTeX
@article{Xu2025,
author = {Xu, Jing and Zhu, Yulong and Wei, Yi and Gan, Peirong and Xia, Shilin and Li, Ya and Jiang, Xiaoman and Wang, Yan and Wu, Hong},
title = {Analyzing How Zhizi Baipi Decoction Regulates VEGF to Suppress RA Angiogenesis Using Network Pharmacology and Experimental Validation},
journal = {Phytochemical Analysis},
year = {2025},
doi = {10.1002/pca.3508}
}
EUVIMED